Decode 100% of the Genome with AI
Lucid Genomics uses AI to decode 100% of the human genome, unlocking insights for better diagnostics and drug discovery. Transforming health through precision and innovation.
Cutting edge science from
All-in-one AI powered platform for variant detection, prioritization and interpretation
100% Genome Coverage
Fast Large-Scale Cohort Analysis
87% Fewer False Positives
Complete Variant Detection
Full Multi-Omics Integration
Lucid Genomics is an all-in-one AI powered platform for variant detection, prioritization and interpretation
100% Genome Coverage
Leveraging AI to analyze the entire genome, including coding and non-coding regions, for comprehensive insights.
Fast Large-Scale Cohort Analysis
Tertiary analysis for hundreds of samples and thousands of genes in few seconds.
87% Fewer False Positives
Reduction of false positives while matching benchmark algorithms in true positive identification.
Complete Variant Detection
Identification and interpretation of all types of genetic variants with precision.
Full Multi-Omics Integration
Full multi-layer analysis and prioritization in tertiary analysis.
Multi-level genome analysis
Analyses the whole genome on cohort, family or individual level tailored to your need.
Variation detection and ranking
Through the detection, ranking, and prioritization of mutations, you are provided with a manageable list of suggested pathogenic mutations.
The technology behind Lucid Genomics
Detection
High-quality detection methods that decrease false-positive structural variants by 87%, including DEL, DUP, INS and INV.
Prioritization
Disease-agnostic AI tool ranks over 80% of known pathogenic variants in the top 10. On top of that, we created a disease-specific scoring system with over 90% accuracy, it ensures precise prioritization for more reliable research outcomes.
Sign up for our newsletter to stay informed about
Lucid Genomics
Start now!
Get a personalized walkthrough of our platform and see how it can benefit your needs.
Resources
Bayer Co.Lab opening in Berlin
2024 Nov. 10
Lucid Genomics and other inspiring start-ups were invited to pitch at the Bayer Co.Lab opening in Berlin.
Visit of the French Minister of Higher Education
2024 Nov. 08
Welcoming French Minister of Higher Education and Research Patrick Hetzel to K.I.E.Z. Künstliche Intelligenz Entrepreneurship Zentrum.
Time to celebrate Lucid Genomics
2024 Oct. 31
We enjoyed celebrating our first event with everyone who supported our journey and discussed recent developments in our field.
Lucid Genomics is fully GDPR compliant
What we offer
Comprehensive genome analysis
Analyses the whole genome on cohort, family or individual level tailored to your need.
Variation detection and ranking
Through the detection, ranking, and prioritization of mutations, you are provided with a manageable list of suggested pathogenic mutations.
